Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Indoleamides are active against drug-resistant Mycobacterium tuberculosis.

Nature communications - 1 Jan 2013

Lun Shichun, Guo Haidan, Onajole Oluseye K, Pieroni Marco, Gunosewoyo Hendra, Chen Gang, Tipparaju Suresh K, Ammerman Nicole C, Kozikowski Alan P, Bishai William R

Abstract excerpt

Responsible for nearly two million deaths each year, the infectious disease tuberculosis remains a serious global health challenge. The emergence of multidrug- and extensively drug-resistant strains of Mycobacterium tuberculosis confounds control efforts, and new drugs with novel molecular targets are desperately needed. Here we describe lead compounds, the indoleamides, with potent activity against both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anion Transport Proteins
Share to Antitubercular Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Design

Share to Drug Resistance, Multiple, Bacterial

Share to Indoles

Share to Molecular Targeted Therapy

Share to Tuberculosis, Multidrug-Resistant

Share to Vero Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 24352433
DOI: 10.1038/ncomms3907
PMCID: PMC3909880

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Indoleamides are active against drug-resistant Mycobacterium tuberculosis.PMID 24352433Read ↗

Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis InfectionSemantic proximity Read ↗

Tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide and N-benzyl-6',7'-dihydrospiro[piperidine-4,4'-thieno[3,2-c]pyran] analogues with bactericidal efficacy against Mycobacterium tuberculosis targeting MmpL3.Semantic proximity Read ↗

HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid TransporterSemantic proximity Read ↗

Mycobacterial Membrane Protein Large 3 (MmpL3) Inhibitors: A Promising Approach to Combat TuberculosisSemantic proximity Read ↗

Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus InfectionsSemantic proximity Read ↗

MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial InfectionsSemantic proximity Read ↗

Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus.Semantic proximity Read ↗

Thienopyrimidine amide analogs target MmpL3 in Mycobacterium tuberculosis.Semantic proximity Read ↗

Multidrug-resistant tuberculosis: a comprehensive review of pathogenesis, drug resistance, current treatment and future prospects.Semantic proximity Read ↗

Drug-Resistant Tuberculosis 2020: Where We StandSemantic proximity Read ↗

A piperidinol-containing molecule is active against Mycobacterium tuberculosis by inhibiting the mycolic acid flippase activity of MmpL3Semantic proximity Read ↗

Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.